Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

PRME

Prime Medicine Inc

May 12 • 02:32PM ET

3.34

+0.10 3.09 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: BEAM EDIT NTLA CRSP FATE

| Held by: ARKG XBI VTI IWM VXF IWN IBB VTWO SCHA VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.25	Insider Own	47.66%	Shs Outstand	180.62M	Perf Week	-1.47%
Market Cap	603.26M	Forward P/E	-	EPS next Y	-0.91	Insider Trans	0.00%	Shs Float	94.54M	Perf Month	-8.74%
Enterprise Value	582.27M	PEG	-	EPS next Q	-0.26	Inst Own	41.49%	Short Float	32.11%	Perf Quarter	-2.34%
Income	-198.37M	P/S	149.69	EPS this Y	26.18%	Inst Trans	4.42%	Short Ratio	12.50	Perf Half Y	-12.34%
Sales	4.03M	P/B	7.87	EPS next Y	9.01%	ROA	-63.69%	Short Interest	30.35M	Perf YTD	-3.75%
Book/sh	0.42	P/C	4.45	EPS next 5Y	15.52%	ROE	-216.07%	52W High	6.94 -51.87%	Perf Year	149.25%
Cash/sh	0.75	P/FCF	-	EPS past 3/5Y	2.55% -91.28%	ROIC	-108.60%	52W Low	1.11 200.90%	Perf 3Y	-73.74%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -2.32%	Gross Margin	-85.35%	Volatility	10.74% 7.10%	Perf 5Y	-
Dividend TTM	-	EV/Sales	144.48	EPS Y/Y TTM	24.20%	Oper. Margin	-5121.76%	ATR (14)	0.26	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.80	Sales Y/Y TTM	4.89%	Profit Margin	-4917.55%	RSI (14)	43.70	Recom	1.67
Dividend Gr. 3/5Y	- -	Current Ratio	3.80	EPS Q/Q	30.04%	SMA20	-6.56%	Beta	2.33	Target Price	7.16
Payout	-	Debt/Eq	1.49	Sales Q/Q	-41.13%	SMA50	-7.70%	Rel Volume	1.01	Prev Close	3.24
Employees	146	LT Debt/Eq	1.38	Earnings	May 07 BMO	SMA200	-17.10%	Avg Volume	2.43M	Price	3.34
IPO	Oct 20, 2022	Option/Short	Yes / Yes	EPS/Sales Surpr.	-11.60% -63.24%	Trades		Volume	1,936,333	Change	3.09%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)